Document is current
Any future updates will be listed below
-
Authors
Ali, Shaukat https://orcid.org/0000-0002-6513-2560
Shalim, Elisha
Farhan, Farah
Anjum, Fatima
Ali, Ayesha
Uddin, Syed Muneeb
Shahab, Faisal
Haider, Mustafa
Ahmed, Iqra
Ali, Mir Rashid
Khan, Sadaf
Rao, Sadia
Guriro, Kabeer
Elahi, Saud
Ali, Muhammad
Mushtaq, Tehreem
Sayeed, Muneeba Ahsan
Muhaymin, Sheikh Muhammad
Luxmi, Shoba
Saifullah,
Qureshi, Saeed
-
Funding
Funding for this research was provided by:
Higher Education Commision, Pakistan (RRG-134)
- License Information
-
More Information
Article History
Received: 23 March 2022
Accepted: 21 October 2022
First Online: 8 November 2022
Declarations
:
: The trial has been approved from the following authorities:Dow University of Health Sciences Institutional Review Board reference no: IRB-2015/DUHS/Approval/2021/353.National Bioethics Committee, Pakistan reference no: 4-87/COVID-60/NBC/21/1267.Drug Regulatory Authority of Pakistan.Informed consent will be taken from all study participants.
: All participants will sign informed consent by themselves or their legally authorized representatives to participate in the study. Model consent form can be provided on request.
: The authors declare that they have no competing interests.
